激素受体阳性HER2-阴性高级乳腺癌的当前管理和未来前景
1Macquarie University Hospital, Sydney, New South Wales, Australia.
Seminars in oncology nursing
|December 20, 2023
概括
治疗激素受体阳性,HER2阴性晚期乳腺癌的进展提高了生存率. 专业护士对于患者的支持,坚持和管理毒性,提高寿命和生活质量至关重要.
科学领域:
- 在瘤学瘤学.
- 护理科学 护理科学
背景情况:
- 激素受体阳性,人体表皮生长因子受体2 (HER2) 阴性晚期乳腺癌是一个重大的临床挑战.
- 最佳的管理需要对当前和新兴的治疗策略有深入的了解.
研究的目的:
- 为提供对激素受体阳性,HER2阴性晚期乳腺癌的治疗方法的概述.
- 讨论新出现的治疗进展和护理在患者护理中的作用.
主要方法:
- 一个全面的对同行评审文章的综述.
- 数据来源于电子数据库.
主要成果:
- 目前和新兴的治疗方法已经改善了这种乳腺癌亚型患者的整体存活率.
- 专业护士对于整体的患者支持至关重要,确保患者坚持治疗.
结论:
- 护士在患者教育,早期毒性管理和克服坚持障碍方面至关重要.
- 有效的护理干预措施提高了患者的寿命和生活质量.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.7K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
